Psoriatic arthritis
National Arthritis Week: 7th–13th October
We’re one day into National Arthritis Week and Arthritis Research UK is asking for information from people with arthritis and funding for its Joint Effort Pledge.
Last year more than 9,000 people completed the National Arthritis Survey, helping the charity to understand the impact of arthritis on the UK population and how the condition is seen and understood. Continue reading
BackCare Awareness Week message to carers: watch your back!
BackCare Awareness Week starts today and this year the British Chiropractic Association (BCA) has developed the following simple tips for the 6.5 million carers in the UK to help them while they’re helping others.
• Think ahead – assess each situation and look for the best and easiest way to achieve the desired result. This may mean using any available equipment whether it be for specialist lifting or a simple sack barrow for moving boxes of supplies. Continue reading
Under the spotlight: reflexology
Used to heal since ancient Egyptian times, we look at how reflexology may help people with arthritis
Reflexology is a complementary therapy that hinges on the belief that there are reflex areas in the feet and hands that correspond to the organs and glands of the body. Stimulating these areas correctly can create a positive effect in the corresponding part of the body.
Evidence exists that reflexology has been practised since ancient Egyptian times. Today it is relatively common – and can be used to treat arthritis according to the British Reflexology Association. Continue reading
Molecule from centipede venom may fight chronic pain
A molecule in centipede venom could form the basis of a new drug that fights pain as effectively as morphine, says a paper published in the Proceedings of the National Academy of Sciences.
Australian and Chinese researchers studied the venom of the Chinese red-headed centipede in an effort to bring hope to millions of people whose lives are blighted by chronic pain. Continue reading
New drug for psoriatic arthritis given thumbs up
People in the EU who have psoriatic arthritis will be able to access ustekinumab (Stelara) following its approval by the regulatory body the European Commission.
Ustekinumab can be used alone or in combination with methotrexate in the treatment of active psoriatic arthritis in adults who have not responded to treatment with non-biological disease-modifying anti-rheumatic drugs. Continue reading
